NO148922C - Analogifremgangsmaate for fremstilling av et polypeptid-derivat som virker forsterkende paa den glukosestimulerte insulinsekresjon - Google Patents

Analogifremgangsmaate for fremstilling av et polypeptid-derivat som virker forsterkende paa den glukosestimulerte insulinsekresjon

Info

Publication number
NO148922C
NO148922C NO793111A NO793111A NO148922C NO 148922 C NO148922 C NO 148922C NO 793111 A NO793111 A NO 793111A NO 793111 A NO793111 A NO 793111A NO 148922 C NO148922 C NO 148922C
Authority
NO
Norway
Prior art keywords
enhances
glucose
preparing
polypeptide derivative
stimulated insulin
Prior art date
Application number
NO793111A
Other languages
English (en)
Norwegian (no)
Other versions
NO793111L (no
NO148922B (no
Inventor
Hans Kofod
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of NO793111L publication Critical patent/NO793111L/no
Publication of NO148922B publication Critical patent/NO148922B/no
Publication of NO148922C publication Critical patent/NO148922C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/645—Secretins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO793111A 1978-09-28 1979-09-27 Analogifremgangsmaate for fremstilling av et polypeptid-derivat som virker forsterkende paa den glukosestimulerte insulinsekresjon NO148922C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK430478 1978-09-28

Publications (3)

Publication Number Publication Date
NO793111L NO793111L (no) 1980-03-31
NO148922B NO148922B (no) 1983-10-03
NO148922C true NO148922C (no) 1984-01-11

Family

ID=8132257

Family Applications (2)

Application Number Title Priority Date Filing Date
NO793112A NO148923C (no) 1978-09-28 1979-09-27 Analogifremgangsmaate for fremstilling av et polypeptid-derivat som virker hemmende paa den glukosestimulerte insulinsekresjon og forsterkende paa glukoseomsetningen
NO793111A NO148922C (no) 1978-09-28 1979-09-27 Analogifremgangsmaate for fremstilling av et polypeptid-derivat som virker forsterkende paa den glukosestimulerte insulinsekresjon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO793112A NO148923C (no) 1978-09-28 1979-09-27 Analogifremgangsmaate for fremstilling av et polypeptid-derivat som virker hemmende paa den glukosestimulerte insulinsekresjon og forsterkende paa glukoseomsetningen

Country Status (16)

Country Link
US (1) US4356119A (de)
JP (2) JPS5569550A (de)
AT (1) AT375338B (de)
AU (2) AU526149B2 (de)
BE (2) BE879087A (de)
CA (2) CA1158640A (de)
CH (2) CH648567A5 (de)
DE (2) DE2939109A1 (de)
ES (2) ES484926A1 (de)
FI (2) FI68245C (de)
FR (2) FR2437399A1 (de)
GB (2) GB2031436B (de)
IT (2) IT1125421B (de)
NL (2) NL7907188A (de)
NO (2) NO148923C (de)
SE (2) SE7907938L (de)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA685075A (en) * 1964-04-21 Schwyzer Robert Polypeptides and process for their manufacture
CA798855A (en) * 1968-11-12 Bernardi Luigi Process for preparing a new undecapeptide
CA616330A (en) * 1961-03-14 Schwyzer Robert Polypeptide and derivatives thereof and process for their manfuacture
GB1064417A (en) * 1963-12-09 1967-04-05 Kyowa Hakko Kogyo Kk Process for the preparation of copolypeptides
US3400118A (en) * 1966-05-27 1968-09-03 Squibb & Sons Inc Intermediates in the preparation of secretin
US3832337A (en) * 1970-07-28 1974-08-27 Squibb & Sons Inc Peptide enzyme inhibitors
US3856770A (en) * 1972-03-08 1974-12-24 Akzona Inc Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175988C (nl) * 1972-05-24 1985-02-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175618C (nl) * 1972-07-15 1984-12-03 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.
DE2315271C3 (de) * 1973-03-27 1975-09-11 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L- Norleucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US3975365A (en) * 1975-01-27 1976-08-17 G. D. Searle & Co. Inhibitory octapeptides angiotensin II
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
US4024121A (en) * 1976-01-27 1977-05-17 Schally Andrew Victor (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4110321A (en) * 1976-07-12 1978-08-29 Folkers Karl Synthetic tridecapeptide [Gln4 ]-neurotensin having hormonal activity
US4086220A (en) * 1976-08-09 1978-04-25 G. D. Searle & Co. Fragments of secretin

Also Published As

Publication number Publication date
ATA634679A (de) 1983-12-15
NO148923B (no) 1983-10-03
ES484926A1 (es) 1980-07-01
FR2437400A1 (fr) 1980-04-25
NL7907187A (nl) 1980-04-01
FI68244C (fi) 1985-08-12
SE7907939L (sv) 1980-03-29
CA1140116A (en) 1983-01-25
IT7926111A0 (it) 1979-09-28
BE879086A (fr) 1980-03-28
CH648567A5 (de) 1985-03-29
NO148923C (no) 1984-01-11
GB2031435A (en) 1980-04-23
AU5124579A (en) 1980-04-03
SE7907938L (sv) 1980-03-29
NL7907188A (nl) 1980-04-01
IT1125422B (it) 1986-05-14
FI68244B (fi) 1985-04-30
NO793111L (no) 1980-03-31
FR2437399B1 (de) 1983-01-28
GB2031436B (en) 1982-10-20
AU533684B2 (en) 1983-12-08
IT1125421B (it) 1986-05-14
FI68245B (fi) 1985-04-30
US4356119A (en) 1982-10-26
ES484928A1 (es) 1980-07-01
FR2437399A1 (fr) 1980-04-25
DE2939135A1 (de) 1980-04-17
CA1158640A (en) 1983-12-13
FI793002A (fi) 1980-03-29
AT375338B (de) 1984-07-25
JPS5576849A (en) 1980-06-10
FR2437400B1 (de) 1984-06-15
GB2031436A (en) 1980-04-23
IT7926112A0 (it) 1979-09-28
FI793001A (fi) 1980-03-29
BE879087A (fr) 1980-03-28
DE2939109A1 (de) 1980-04-10
NO793112L (no) 1980-03-31
GB2031435B (en) 1982-11-10
CH648568A5 (de) 1985-03-29
JPS5569550A (en) 1980-05-26
FI68245C (fi) 1985-08-12
AU5124679A (en) 1980-04-03
AU526149B2 (en) 1982-12-16
NO148922B (no) 1983-10-03

Similar Documents

Publication Publication Date Title
NO167673C (no) Fremgangsmaate for fremstilling av et polypeptid.
NO160261C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n-metyl-11-aza-10-deokso-10-dihydroerytromycin a.
DK153552C (da) Analogifremgangsmaade til fremstilling af 1,8-naphthyridinderivater
NO153854C (no) Fremgangsmaate for fremstilling av en vandig ionisk polyuretandispersjon.
NL184722C (nl) Meercomponentencapsule voor tandtechnische doeleinden.
NO146698C (no) Fremgangsmaate for fremstilling av et stabilt langtidsvirkende insulinprodukt.
NO790300L (no) Fremgangsmaate for fremstilling av en pulverformig vaskemiddelblanding.
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
DK157060C (da) Fremgangsmaade til fremstilling af en liposomsuspension, der indeholder et laegemiddel
DK153844C (da) Analogifremgangsmaade til fremstilling af 1,2,3,5-tetrahydroimidazothienopyrimidin-2-oner
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
DK145698C (da) Analogifremgangsmaade til fremstilling af 2-alkoxyadeninderivater
NO150762C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 1-aza-2-(2,2,2)-bicyklo-oktan
NL7805066A (nl) Verpakking voor radiofarmaceutische preparaten.
NO159591C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbostyrilderivat.
NO791514L (no) Fremgangsmaate for fremstilling av en innretning for regulert, kontinuerlig administrering av kjemikalier
NO810133L (no) Fremgangsmaate for fremstilling av et avfoeringsmiddel.
IT7924129A0 (it) Procedimento per preparare poliolefine.
NO153916C (no) Fremgangsmaate for fremstilling av en stabil, injiserbar opploesning av et oksytetracyklinchelat.
ES484446A0 (es) Un procedimiento de preparacion de derivados del jurano
SE7504882L (sv) Forfarande for framstellning av ett nytt farmaceutiskt preparat.
NO790994L (no) Fremgangsmaate for fremstilling av et soyasapogenolderivat
NL7904215A (nl) Optisch actieve oxazaforforinederivaten en een werk- wijze voor de bereiding daarvan.
SE7908629L (sv) Ett nytt forfarande for framstellning av 6-piperidino-2,4-diaminopyrimidin-3-oxid
NO148373C (no) Fremgangsmaate ved fremstilling av et harpikspeptid.